Graham Capital Management’s Mesa Laboratories MLAB Stock Holding History

Graham Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	2,859 -470	-14%	-$47.3K	0.01%	915
2026 Q1	$294K	Sell	3,329 -394	-11%	-$33.9K	0.01%	819
2025 Q4	$292K	Buy	+3,723	New	+$283K	0.01%	869
2022 Q4	–	Sell	-6,796	Closed	-$957K	–	1212
2022 Q3	$957K	Buy	6,796 +3,062	+82%	+$559K	0.04%	507
2022 Q2	$761K	Buy	3,734 +2,728	+271%	+$597K	0.03%	524
2022 Q1	$256K	Buy	+1,006	New	+$273K	0.01%	775

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Graham Capital Management's MLAB Position: Q2 2026 in Review

Graham Capital Management reduced its Mesa Laboratories (MLAB) stake by 14% in Q2 2026, selling an estimated $47.3K and leaving 2,859 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #915.

Graham Capital Management first reported a position in MLAB in Q1 2022 and has held it in 6 quarters since. The position peaked at $957K in Q3 2022. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Graham Capital Management held 2,859 shares of Mesa Laboratories worth $285K as of Q2 2026.
Graham Capital Management sold 470 Mesa Laboratories shares in Q2 2026, an estimated $47.3K.
Mesa Laboratories made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #915 holding.
Graham Capital Management first reported a position in Mesa Laboratories in Q1 2022 and has held it in 6 quarters since.
Graham Capital Management's Mesa Laboratories position peaked at $957K in Q3 2022.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.